Ann: Hardware and Wearable Devices to Expand ResApp's Markets, page-4

Extract from the announcement:-

  “A decision on our CE Mark application for our mobile software diagnostic app is expected shortly (my emphasis) and if approved will allow European commercialisation for running on off-the-shelf smartphones and also, once development is complete, this new handheld device. Being able to offer this option to customers will provide an additional selling point to our already strong value proposition for in-person care. Furthermore, a wearable monitor will allow us to commercialise new products aimed at assessing and predicting respiratory disease progression,” said Tony Keating, CEO and Managing Director of ResApp. “By outsourcing hardware development, we retain our focus on delivering clinical-quality algorithms for use on smartphones in telehealth and in-person settings, while increasing our addressable market by having additional, specialised platforms on which we can deliver our algorithms. Having a milestone-based payment structure, where we can choose to pay milestones either in cash or shares, reduces our financial risk and helps optimise our cash flow.”